| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 01/17/2002 | WO2002004451A2 Methods for stimulation of synthesis of synaptophysin in the central nervous system |
| 01/17/2002 | WO2002004450A2 Methods for prevention of accumulation of amyloid beta peptide in the central nervous system |
| 01/17/2002 | WO2002004448A2 Methods for treatment of drug-induced peripheral neuropathy and related conditions |
| 01/17/2002 | US20020006635 Stereoselectively hydrolyzing an anomeric mixture of 2-benzoyloxydioxolanecarboxylate with an enzyme; separating product; replacing carboxylate by reaction with a purine or pyrimidinyl derivative |
| 01/16/2002 | EP1172365A1 Process for preparing 2,6-dichloropurine |
| 01/16/2002 | EP1171442A1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 01/15/2002 | US6338963 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 01/10/2002 | WO2002002560A2 Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv) |
| 01/10/2002 | WO2001034604A3 Adenosine receptor antagonists and methods of making and using the same |
| 01/10/2002 | US20020004598 Process for preparing 2,6-dichloropurine |
| 01/10/2002 | US20020004508 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/10/2002 | CA2411864A1 Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv) |
| 01/09/2002 | EP1169321A2 Purine derivatives having phosphodiesterase iv inhibition activity |
| 01/09/2002 | EP1169298A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169294A2 Pharmaceutical compounds |
| 01/09/2002 | EP0996617B1 2,4-Dithi(oxo)-pyridin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists |
| 01/09/2002 | CN1330073A Peptide nucleic acid derivatives, intermediate for preparing them and medicinal composition containing them |
| 01/03/2002 | WO2002000659A2 Methods of synthesis for 9-substituted hypoxanthine derivatives |
| 01/03/2002 | WO2002000200A1 Novel process for preparing crystalline particles |
| 01/03/2002 | US20020002145 Adenosine A2A receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 01/03/2002 | DE10030375A1 Verwendung von MTP-Inhibitoren zur Senkung von ppTRL Use of MTP inhibitors to reduce ppTRL |
| 01/02/2002 | EP1165566A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 01/02/2002 | EP1165561A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents |
| 01/02/2002 | EP1165560A1 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents |
| 01/02/2002 | EP1165545A1 Novel compounds |
| 01/02/2002 | EP1165530A2 Dihetero-substituted metalloprotease inhibitors |
| 01/02/2002 | EP0912553B1 BENZO[g]QUINOLINE DERIVATIVES |
| 01/02/2002 | CN1329497A Cmbination therapy to treat hepatitis b virus |
| 01/02/2002 | CN1328824A Compound for curing female sexual disorder |
| 01/01/2002 | US6335432 For fluorescent hybridization probes for use in diagnosis, research, and therapy |
| 01/01/2002 | CA2056799C 1,4-dihydropyridine derivatives and methods of producing the same |
| 12/27/2001 | WO2001098522A2 Positively-charged peptide nucleic acid analogs with improved properties |
| 12/27/2001 | WO2001098290A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/27/2001 | WO2001097787A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 12/27/2001 | CA2414085A1 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/27/2001 | CA2413556A1 Positively-charged peptide nucleic acid analogs with improved properties |
| 12/27/2001 | CA2413277A1 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 12/25/2001 | US6333344 Prolines as antimicrobial agents |
| 12/25/2001 | US6333331 Useful in inactivating the human dna repair protein o.sup.6 -alkylguanine-dna alkyltransferase; anticancer agents |
| 12/20/2001 | WO2001096339A1 Novel telomerase inhibitors |
| 12/20/2001 | WO2001095910A1 Imidazopyridine and imidazopyrimidine antiviral agents |
| 12/20/2001 | CA2412327A1 Imidazopyridine and imidazopyrimidine antiviral agents |
| 12/19/2001 | EP1164133A2 Enantiomerically pure Beta-D-(-)-dioxolane-nucleosides |
| 12/19/2001 | EP0728001B1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections |
| 12/19/2001 | EP0639080B1 Non-azo naphthalimide dyes and use as alkylating agents |
| 12/18/2001 | US6331543 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 12/13/2001 | WO2001094348A1 Antiviral agents |
| 12/13/2001 | WO2001093841A2 Barbituric acid analogs as therapeutic agents |
| 12/13/2001 | WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters |
| 12/13/2001 | US20010051348 Complexing |
| 12/12/2001 | EP0728002B1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection |
| 12/12/2001 | CN1326351A Use of certain drugs for treating nerve root injury |
| 12/12/2001 | CN1326349A Antiviral combinations of lamivudine and adefovir |
| 12/11/2001 | US6329522 Glycosylating purine or pyrimidine base or analogue thereof with oxathiolan or dithiolan derivative in presence of lewis acid catalyst |
| 12/11/2001 | US6329381 Interferons, viricides and anticarcinogenic agents |
| 12/11/2001 | US6329144 Probe for analysis of target nucleic acids |
| 12/06/2001 | US20010049372 Antiviral nucleoside analogues |
| 12/05/2001 | CN1325308A Use of neurotrophic factor stimulators for treatment of ophthalmic neurodegenerative diseases |
| 12/04/2001 | US6326359 Adenosine A2A receptor agonists as antiinflammatory agents |
| 12/04/2001 | CA2237730C Method and compositions for the synthesis of dioxolane nucleosides with .beta.-configuration |
| 11/29/2001 | WO2001090121A2 Methods and compositions for treating hepatitis c virus |
| 11/29/2001 | WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 11/29/2001 | WO2001060835A8 Purine derivatives |
| 11/29/2001 | CA2712547A1 Methods and compositions for treating hepatitis c virus |
| 11/29/2001 | CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 11/28/2001 | CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 11/27/2001 | US6323201 Compounds for inhibition of ceramide-mediated signal transduction |
| 11/22/2001 | WO2001087299A1 Aralkyl ester soft drugs |
| 11/22/2001 | WO2001087235A2 Method for producing[18f]fluoride ion |
| 11/22/2001 | US20010044535 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration |
| 11/22/2001 | US20010044441 And female sexual dysfunction, premature labour or dysmenorrhea |
| 11/22/2001 | CA2407099A1 Aralkyl ester soft drugs |
| 11/21/2001 | EP1155025A1 Platinum (ii) compounds |
| 11/21/2001 | EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 11/21/2001 | EP0873340B1 Heterocyclic substituted cyclopentane compounds |
| 11/21/2001 | CN1323309A Phenyl yanthine derivatives |
| 11/21/2001 | CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 11/21/2001 | CN1322526A Compound for treating female sexual dysfunction |
| 11/21/2001 | CN1074925C Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections |
| 11/20/2001 | US6319928 Asthma, allergies, inflammation,depression, dementia, alzheimer's disease, vascular and multi-in-farct dementia and disease caused by human immunodeficiency virus treatment; efficiency and selectivity |
| 11/15/2001 | WO2000064484A3 Conjugate having a cleavable linkage for use in a liposome |
| 11/15/2001 | US20010041797 Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties |
| 11/14/2001 | EP1153924A2 Substituted 1,3-oxathiolanes with antiviral properties |
| 11/14/2001 | EP1153024A1 2-amino-6-anilino-purines and their use as medicaments |
| 11/13/2001 | US6316607 Electrochemiluminescent assays |
| 11/13/2001 | US6316595 PNA synthesis using a base-labile amino protecting group |
| 11/13/2001 | US6316482 Benzamide derivatives having a vasopressin antagonistic activity |
| 11/13/2001 | US6316458 Method of enhancing insulin action |
| 11/13/2001 | US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 11/13/2001 | US6316456 Purine derivatives having, in particular, antiproliferative properties, and their biological uses |
| 11/13/2001 | US6316455 Method of improving the effectiveness of a cytotoxic drug or radiotherapy using a quinazolinone compound |
| 11/08/2001 | WO2001083472A1 Muscarinic agonists |
| 11/08/2001 | WO2001082905A1 Pharmaceutical formulation comprising carrier beads coated with a layer of valaciclovir |
| 11/08/2001 | CA2433897A1 Pharmaceutical formulation comprising carrier beads coated with a layer of valaciclovir |
| 11/08/2001 | CA2407594A1 Muscarinic agonists |
| 11/07/2001 | EP1150982A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND I$g(k)-A$g(a) |
| 11/07/2001 | EP1150981A1 Therapeutic nucleoside compound |
| 11/07/2001 | EP1150565A1 Thiazole derivatives and combinatorial libraries thereof |
| 11/07/2001 | EP0799039B1 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections |
| 11/07/2001 | CN1320426A Compound for treatment of female sexual dysfuction |